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Abstract
Kainate receptors are ionotropic glutamate receptors located postsynaptically, mediating frequency-dependent transmission, and presy-
naptically, modulating transmitter release. In contrast to the excitatory postsynaptic kainate receptors, presynaptic kainate receptor can also
be inhibitory and their effects may involve a metabotropic action. Arachidonic acid (AA) modulates most ionotropic receptors, in particular
postsynaptic kainate receptor-mediated currents. To further explore differences between pre- and postsynaptic kainate receptors, we tested
if presynaptic kainate receptors are affected by AA. Kainate (0.3–3M) and the kainate receptor agonist, domoate (60–300 nM), inhibited
by 19–54% the field excitatory postsynaptic potential (fEPSP) slope in rat CA1 hippocampus, and increased by 12–32% paired-pulse facil-
itation (PPF). AA (10M) attenuated by 37–72% and by 62–66% the domoate (60–300 nM)-induced fEPSP inhibition and paired-pulse
facilitation increase, respectively. This inhibition by AA was unaffected by cyclo- and lipo-oxygenase inhibitors, indomethacin (20M)
and nordihydroguaiaretic acid (NDGA, 50M) or by the free radical scavenger, N-acetyl-l-cysteine (0.5 mM). The K+ (20 mM)-evoked
release of [3H]glutamate from superfused hippocampal synaptosomes was inhibited by 18–39% by domoate (1–10M), an effect attenu-
ated by 35–63% by AA (10M). Finally, the KD (40–55 nM) of the kainate receptor agonist [3H]-(2S,4R)-4-methylglutamate ([3H]MGA)
(0.3–120 nM) binding to hippocampal synaptosomal membranes was increased by 151–329% by AA (1–10M). These results indicate
that AA directly inhibits presynaptic kainate receptor controlling glutamate release in the CA1 area of the rat hippocampus.
© 2003 Elsevier Ltd. All rights reserved.
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1. Introduction
Kainate receptors are a subtype of ionotropic glutamate
receptors that are abundantly expressed in the hippocampus
(for review see, Lerma et al., 2001). Kainate receptors me-
diate frequency-dependent transmission in mossy fiber/CA3
pyramidal cell synapses and in CA1 interneurons (reviewed
in Kamiya, 2002). Kainate receptors also fulfil a neuromod-
ulatory role in the hippocampus, mainly through a presy-
naptic action (reviewed in Malva et al., 2003). Interestingly
in the hippocampal CA1 area, a robust activation of presy-
naptic kainate receptors leads to inhibition of glutamatergic
transmission and glutamate release (e.g. Chittajallu et al.,
1996; Kamiya and Ozawa, 1998) as well as GABAergic
transmission and GABA release (e.g. Rodrı´guez-Moreno
and Lerma, 1998; Cunha et al., 2000a). These presynaptic
inhibitory effects are at odds with the expected depolar-
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izing effect of kainate receptor-gated ionotropic channels
permeable to cations (reviewed in Lerma et al., 2001). In-
terestingly, it was found that the inhibition of GABA and
glutamate release by activation of kainate receptors in the
CA1 area of the hippocampus involves a metabotropic path-
way since it is disrupted by interference with Gi/Go protein
(Rodrı´guez-Moreno and Lerma, 1998; Cunha et al., 2000a;
Frerking et al., 2001). Surprisingly, the only pharmacologi-
cal difference between these presynaptic kainate receptors
triggering metabotropic responses and their postsynaptic
counterparts ion channels is a different sensitivity to ago-
nists in the case of GABAergic neurons (Rodrı´guez-Moreno
et al., 2000).
It was reported that cis-unsaturated fatty acids, like the
trans-cellular messenger arachidonic acid (AA; see Lynch
et al., 1991), inhibit kainate receptor-mediated responses
(Wilding et al., 1998). In this work (Wilding et al., 1998),
it was reported that AA inhibits the currents triggered by
kainate receptor activation but it is not known if AA also
affects presynaptic kainate receptors. Indeed, in contrast to
the AA modulation of ion channels, which normally results
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from a direct interaction of AA with voltage sensitive ion
channels or receptor-operated ion channels (e.g. Kovalchuck
et al., 1994; Meves, 1994; Miller et al., 1992; Wilding et al.,
1998), the AA modulation of metabotropic receptors in-
volves the activation of protein kinase C (e.g. Cunha and
Ribeiro, 1999; Cunha et al., 2000b; Freeman et al., 1990).
Thus, as a way to further elucidate the nature of presynap-
tic kainate receptors controlling hippocampal glutamatergic
transmission, we now tested if presynaptic inhibitory re-
sponses mediated by kainate receptors in the hippocampus
were also sensitive to AA.
2. Methods
2.1. Chemicals and solutions
Domoic acid, 5-nitro-6,7,8,9-tetrahydrobenzo(g)indole-
2,3-dione-3-oxime (NS-102) and 1-(4-aminophenyl)-4-
methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine (GYKI
52466) were from Research Biochemicals International,
kainate, bovine serum albumin (BSA, fatty acid free),
N-acetyl-l-cysteine, indomethacin, nordihydroguaiaretic
acid (NDGA), linolenic acid, arachidic acid, ETYA
(5,8,11,14-eicosatetraynoic acid) and arachidonic acid were
from Sigma, [3H]-(2S,4R)-4-methylglutamate ([3H]MGA)
and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) were
from Tocris Cookson and [3H]glutamate (specific activ-
ity 45 Ci/mmol) was from Amersham. Free fatty acids
were made up into a 30 mM stock solution in ethanol,
aliquoted and stored under nitrogen atmosphere at −20 ◦C.
Indomethacin was made up into a 20 mM stock in methanol
and nordihydroguaiaretic acid was made up into a 20 mM
stock in ethanol. GYKI 52466 was made up in a 1 mg/ml
solution in methanol and NS-102 was made up in a 5 mM
stock in dimethylsulfoxide. Aqueous dilutions of these stock
solutions were made daily. The maximal concentrations of
ethanol, methanol or dimethylsulfoxide used were devoid
of effects on synaptic transmission and on [3H]glutamate
release.
2.2. Electrophysiological recordings of hippocampal
synaptic transmission
The handling and use of the animals was according
with the EU guidelines for use of experimental animals
(86/609/EEC), the rats being anesthetized under halothane
atmosphere before being sacrificed by decapitation to min-
imize suffering. One 400m hippocampal slice, obtained
as previously described (Cunha et al., 2000b) from 6 to
8 weeks old male Wistar rats, was transferred to a 1 ml
recording chamber for submerged slices and continuously
superfused, at a flow rate of 3 ml/min, with gassed (95%
O2 and 5% CO2) Krebs solution, kept at 30 ◦C, of the fol-
lowing composition: NaCl 125 mM, KCl 3 mM, NaH2PO4
1.25 mM, NaHCO3 25 mM, CaCl2 2 mM, MgSO4 1 mM
and glucose 10 mM. Drugs were added to this superfusion
solution. Electrophysiological recordings of field excitatory
postsynaptic potentials (fEPSP) were obtained as previously
described (Cunha et al., 2000b). Stimulation (rectangular
pulses of 0.1 ms applied once every 15 s) was delivered
through a bipolar concentric electrode placed on the Schaf-
fer fibres, in the stratum radiatum near the CA3/CA1 border.
Orthodromically evoked fEPSPs were recorded through
an extracellular microelectrode (4 M NaCl, 2–5 M resis-
tance) placed in the stratum radiatum of the CA1 area. The
intensity of the stimulus was adjusted to evoke a fEPSP
with an amplitude of 0.7–1 mV without appreciable pop-
ulation spike contamination. Recordings were obtained
with an Axoclamp 2B amplifier coupled to a DigiData
1200 interface (Axon Instruments) and averages of eight
consecutive responses were continuously monitored on a
personal computer with the LTP 1.01 software (Anderson
and Collingridge, 1997). Responses were quantified as the
initial slope of the averaged fEPSPs. The amplitude of the
afferent presynaptic volley was quantified as a peak-to-peak
measurement between the negative peak of the presynap-
tic volley and the positivity that immediately preceded
this negative peak (Dunwiddie and Miller, 1993). To elicit
paired-pulse facilitation (PPF), the Schaffer pathway was
stimulated twice with 50 ms inter-pulse interval and the
synaptic facilitation was quantified as the ratio (P2/P1) be-
tween the slopes of the fEPSP elicited by the second (P2)
and the first (P1) stimuli.
2.3. [3H]Glutamate release from hippocampal nerve
terminals
A synaptosomal fraction from the CA1 area of the
rat hippocampus was prepared as previously described
(Lopes et al., 2002) from male Wistar rats (6–8 weeks old;
150–210 g) and resuspended in 1 ml of gassed Krebs solu-
tion. The evoked release of [3H]glutamate was as previously
described (Lopes et al., 2002). Basically, the synaptosomes
were diluted 1:1 in gassed Krebs solution, equilibrated for
10 min at 37 ◦C, and labeled with [3H]glutamate (0.2M)
during 5 min at 37 ◦C under direct but gentle bubbling
with 95% O2 and 5% CO2. The synaptosomal suspension
was then diluted 1:6 with gassed Krebs solution and lay-
ered over Whatman GF/C filters into four parallel 90l
superfusion chamber (adapted from Swinny filter holders,
Millipore) through the aid of a roller pump (flow rate:
0.8 ml/min, which was kept constant through the experi-
ment). A series of four parallel superfusion chambers was
used to enable both control and test conditions to be per-
formed in duplicate from the same batch of synaptosomes.
After setting up the synaptosomes, a 20 min equilibration
period was performed before starting sample collection.
The effluent was then collected in 1 min fractions for scin-
tillation counting (500l to 5 ml Scintran Cocktail T, Wal-
lac). Synaptosomal disruption during the experiments was
small since only 3± 2% of the total lactate dehydrogenase
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(EC 1.1.1.27) was released (see Cunha and Ribeiro,
1999).
The synaptosomes were stimulated with 20 mM KCl (iso-
molar substitution of Na+ by K+ in the Krebs superfusion
solution) at 3 and 9 min after starting sample collection (S1
and S2). At the end of the experiments, the filters were re-
moved from the superfusion chambers and analyzed by scin-
tillation counting for determination of tritium retained by the
synaptosomes. The amount of radioactivity released by each
pulse (S1 and S2) of potassium (evoked release) was calcu-
lated by integration of the area of the peak upon subtraction
of the estimated basal tritium outflow from the total outflow
of tritium obtained upon K+ stimulation. The basal outflow
was assumed to decline linearly from the 2 min interval be-
fore onset of stimulation to the fifth minute after onset of
stimulation. The amount of radioactivity recovered in the
effluent of the evoked release peak was mostly glutamate,
as assessed by HPLC, and was essentially Ca2+-dependent
(see Lopes et al., 2002). Thus, we considered that the evoked
release of tritium in the present experimental conditions cor-
responds to a Ca2+-dependent [3H]glutamate release.
When the effect of domoate on the release of glutamate
was investigated, domoate was added to the superfusion
medium 2 min before S2 and remained in the bath up to the
end of the sample collection period. The effect of domoate
was calculated as the percentage variation of the amount of
tritium released in S2/amount of tritium released in S1 in
the presence of domoate versus the S2/S1 ratio in control
conditions, in the same experiment using the same batch of
synaptosomes. When we evaluated the changes of the effect
of domoate by a modifier, this modifier was applied 15 min
before the beginning of sample collection period and was
present during S1 and S2. When present during S1 and S2,
arachidonic acid (10M), CNQX (10M) or GYKI 52466
(100M) did not significantly (P > 0.05) alter the S2/S1
ratio as compared with the S2/S1 ratio obtained in control
conditions (no added drug).
2.4. Binding assays
Binding of [3H]-(2S,4R)-4-methylglutamate ([3H]MGA)
was for 90 min at 4 ◦C with 116–235g of synaptosomal
membrane protein in a final volume of 300l in the in-
cubation buffer, essentially as previously described (Cunha
et al., 1999). Specific binding was determined by subtrac-
tion of the non-specific binding, which was measured in the
presence of 100M kainate. The binding reactions were
stopped by vacuum filtration through Whatman GF/C glass
fiber filters, followed by washing of the filters and reaction
tubes with 8 ml of incubation buffer, kept at 4 ◦C. The filters
were then placed in scintillation vials with 5 ml of scintil-
lation liquid (Scintran T). Radioactivity bound to the filters
was determined after 12 h with an efficiency of 55–60% for
2 min. Saturation curves were performed in triplicate with
10 different [3H]MGA concentrations ranging from 0.3 to
120 nM. The amount of membrane protein was determined
by the Lowry method (Cunha et al., 1999). The data were
initially processed in Microsoft Excel software to determine
the average specific binding, then fitted by non-linear regres-
sion using the Raphson–Newton method, performed with the
GraphPAD InPlot Software package. An F-test (P > 0.05)
was used to determine whether the curves were fitted best
by one or two independent binding sites.
2.5. Statistics
The values presented are mean±S.E.M. of n experiments,
except KD values which are presented as mean (95% con-
fidence interval). To test the significance of the effect of a
drug versus control, a paired Student’s t-test was used. When
making comparisons from different set of experiments with
control, a one-way variance analysis (ANOVA) was used,
followed by a Dunnett’s test. P ≤ 0.05 was considered to
represent a significant difference.
3. Results
3.1. Synaptic transmission in CA1 area of hippocampal
slices
The superfusion of rat hippocampal slices with increas-
ing concentrations of domoic acid (60–300 nM) caused a
concentration-dependent inhibition of synaptic transmission
in Schaffer fiber/CA1 pyramid synapses, as measured by the
decrease in the initial slope of the field excitatory postsynap-
tic potentials recorded in the stratum radiatum of CA1 area
(Fig. 1). Kainate (0.3–3M) also inhibited the fEPSP slope
(data not shown). The depression of fEPSP caused by do-
moate or kainate fully recovered upon washout of the drugs
and three series of cumulative application of three concentra-
tions of domoate (60, 100 and 300 nM) produced essentially
similar depressions of fEPSP slope (n = 4). In parallel with
the inhibition of fEPSP slope, domoate (60–100 nM) and
kainate (0.3–1M) induced a response with an epileptiform
pattern (see Fig. 1B), which also disappeared upon washout
of the drugs. This domoate-induced epileptogenic-like pat-
tern was attenuated but did not disappear by cutting the con-
nection between CA3/CA2 areas to CA1 area. The amplitude
of the inhibition of fEPSP slope by domoate (60–100 nM)
and kainate (0.3–1M) was similar irrespective of cutting
CA3/CA1 connections. The kainate GluR6 receptor antago-
nist, NS-102 (10M), which by itself was devoid of effects
on fEPSP slope (n = 4), attenuated (47–66%, n = 2 for each
agonist) the inhibitory effect of both domoate (60–300 nM)
and of kainate (0.6–3M) on fEPSP slope. Thus, as previ-
ously concluded by others (Chittajallu et al., 1996; Kamiya
and Ozawa, 1998; Vignes et al., 1998; Frerking et al., 2001),
the effect of domoate and kainate on excitatory synaptic
transmission in hippocampal CA1 area is likely mediated by
kainate receptors.
When arachidonic acid (1–30M) was applied to rat
hippocampal slices, it was essentially devoid of effects on
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Fig. 1. Activation of kainate receptors inhibits synaptic transmission in Schaffer fibres/CA1 pyramid synapses of rat hippocampal slices and this effect
is attenuated by arachidonic acid. Panel A shows an experiment monitoring the time course of field excitatory postsynaptic potential responses and the
effect thereupon of the addition of three successive concentrations (60, 100 and 300 nM) of the kainate receptor agonist, domoic acid first in the absence,
then in the presence, then again in the absence of AA (10M), as indicated in the upper bars. Each point corresponds to the averaged fEPSP slope
of two consecutive fEPSP responses. Panel B shown averaged fEPSP responses at the time points indicated by the symbols ((i)–(vi)) shown above the
abscissa in panel A, i.e. in control conditions (i); in the presence of 60 nM (ii); and 100 nM of domoic acid (iii). In the presence of AA (10M) (iv);
together with 60 nM (v); and 100 nM domoic acid (vi); a significant attenuation of the fEPSP slope induced by domoate was observed. The calibration
bars correspond to 1 mV and 5 ms. Panel C represented the averaged percentage inhibition of fEPSP slope caused by domoic acid in the absence ()
and in the presence of 10M AA (). Zero percent corresponds to the fEPSP slope in control conditions (i.e. in the absence of any added drugs;
458± 31V/ms, a value not modified by 10M AA) and 100% corresponds to the blockade of fEPSP response. Each value is the mean ± S.E.M. of
four experiments. ∗P < 0.05 comparing the effect of each concentration of domoic acid in the absence and in the presence of AA (10M).
fEPSP slope, as previously reported (Cunha et al., 2000b
and references therein). However, in the presence of AA
(10M), the inhibitory effect of domoate (60–300 nM)
on fEPSP slope was significantly (P < 0.05) attenuated
(Fig. 1). As illustrated in Fig. 1C, the inhibitory effect of
AA was more intense at lower concentrations of domoate
and tended to decrease with increasing concentrations
of domoate (Fig. 1C). AA (10M) also depressed the
domoate-induced hyperexcitability in CA1 area as illustrated
in Fig. 1 by the decreased appearance of secondary popu-
lation spikes. AA attenuated in a concentration-dependent
manner the domoate inhibition of fEPSP slope, with a
maximal effect at 10M AA (Fig. 2A). Thus, this con-
centration of AA was used to probe the effect of AA on
hippocampal kainate receptors in most of the remaining
experiments.
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Fig. 2. Arachidonic acid attenuates the domoic acid-induced inhibition
of field excitatory postsynaptic potential responses in a concentra-
tion-dependent manner and this AA effect is not due to lipoxygenase or
cyclooxygenase metabolites and is mimicked by other cis-unsaturated, but
not saturated, free fatty acids. Panel A shows the percentage attenuation
by different concentrations of AA (1–30M) of the inhibitory effect of
domoic acid (100 nM) on fEPSP slope. Zero percent corresponds to the
inhibition of fEPSP slope caused by 100 nM domoic acid (24±4% nhibi-
tion) and 100% corresponds to blockade of the inhibitory effect of domoic
acid, i.e. to the fEPSP slope value in control conditions in the absence of
any drug (529±36V/ms). Each point corresponds to the mean±S.E.M.
of three to four experiments. Panels B and C are also shown the percent-
age attenuation of fEPSP slope caused by 100 nM domoic acid alone
(first bar from the left in panels B and C), together with 10M AA,
together with bovine serum albumin (1%, that quenches free fatty acids),
with the free radical scavenger, N-acetyl-l-cysteine (0.5 mM) with the si-
multaneous presence of the lypoxygenase inhibitor, nordihydroguaiaretic
acid (50M) and the cyclooxygenase inhibitor, indomethacin (Indo,
20M), and of 100 nM domoic acid with the non-hydrolysable AA ana-
logue, EYTA (10M) or with the cis-unsaturated free fatty acid, linoleic
The effect of AA (10M) on domoate (100 nM)-induced
inhibition of fEPSP slope was prevented by bovine serum
albumin (1%, n = 3), which binds free fatty acids (Fig. 2B),
and was unaffected by the oxygen radical scavenger,
N-acetyl-l-cysteine (0.5 mM, n = 3) (Fig. 2B). Nei-
ther BSA (1%, n = 3) nor N-acetyl-l-cysteine (0.5 mM,
n = 3) affected fEPSP slope. The simultaneous presence
of the lipoxygenase inhibitor, nordihydroguaiaretic acid
(50M), and of the cyclooxygenase inhibitor, indomethacin
(20M), also failed to modify the effect of AA (10M)
on domoate (100 nM)-induced inhibition of fEPSP slope
(n = 3) (Fig. 2B). The lack of involvement of AA metabo-
lites was further strengthen by the observation that ETYA
(10M), an analogue of AA that mimics the effect of
AA but cannot be metabolized, also depressed domoate
(100 nM)-induced inhibition of fEPSP slope (n = 3), as
did another cis-unsaturated fatty acid, linoleic acid (10M,
n = 3) (Fig. 2C). In contrast, a C20 saturated free fatty
acid, arachidic acid (10M, n = 2), failed to affect
the domoate (100 nM)-induced inhibition of fEPSP slope
(Fig. 2C).
3.2. Paired-pulse facilitation in CA1 area of hippocampal
slices
When two consecutive pulses are applied to the afferent
Schaffer fibers with an interval of 50 ms, the fEPSP re-
sponse to the second pulse showed a larger slope (Fig. 3)
as a result of presynaptic calcium accumulation (Wu and
Saggau, 1994). This paired-pulse facilitation is enhanced
by drugs presynaptically inhibiting glutamate release and
is inhibited by drugs presynaptically facilitating gluta-
mate release, provided these modulatory systems control
calcium transients (Wu and Saggau, 1994). Consistent
with a presynaptic effect of kainate receptors to modulate
fEPSP in CA1 area (Chittajallu et al., 1996; Kamiya and
Ozawa, 1998; Vignes et al., 1998; Frerking et al., 2001),
domoate (60–300 nM) increased the ratio of PPF in a
concentration-dependent manner (Fig. 3). Like the inhibitory
effect of domoate on fEPSP slope, the PPF ratio rapidly re-
covered to control value upon washout of domoate (data not
shown).
By itself, AA (10M) slightly inhibited PPF (8 ± 2%,
n = 4), probably as a consequence of the ability of AA
to modulate calcium transients in hippocampal nerve termi-
nals (Damron and Dorman, 1993). As illustrated in Fig. 3,
AA (10M) attenuated the facilitatory effect of domoate
(60–300 nM) on PPF.
acid (10M) or with the saturated free fatty acid, arachidic acid (10M).
Each bar is the mean ± S.E.M. of three experiments, except the bar
corresponding to the lack of effect of arachidic acid on 100 nM domoic
acid inhibition on fEPSP slope in panel C, which is mean± S.D. of two
experiments. ∗P < 0.05 compared to the effect of 100 nM domoic acid
alone (first bar from the left in panels B and C).
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Fig. 3. Activation of kainate receptors increases paired-pulse facilitation in rat hippocampal slices and this effect is attenuated by arachidonic acid. Panel
A shows recordings with twin field excitatory postsynaptic potential responses recorded extracellularly in Schaffer fibres/CA1 pyramid synapses upon
two consecutive stimulation pulses separated by 50 ms. In the first trace corresponding to control conditions (i), the second fEPSP response is larger than
the first (PPF); and 100 nM domoic acid (ii) facilitates PPF. In the second row of recordings is first shown the PPF in the presence of 10M AA (iii);
and then in the simultaneous presence of 10M AA and 100 nM domoic acid (iv). The calibration bars correspond to 1 mV and 25 ms. Note that in this
series of recordings, the connection between CA3 and CA1 area was cut and the domoate-induced epileptogenesis (illustrated in the recording in Fig. 1)
is drastically reduced. Panel B represented the average percentage facilitation of PPF caused by domoic acid in the absence () and in the presence of
10M AA (). Zero percent corresponds to the PPF in control conditions (1.88± 0.05 in the absence of any drugs or 1.73± 0.05 in the presence of
10M AA) and 100% corresponds to the double of these values. Each value is the mean± S.E.M. of four experiments. ∗P < 0.05 comparing the effect
of each concentration of domoic acid in the absence and in the presence of 10M AA.
3.3. Glutamate release from hippocampal
synaptosomes
When CA1 hippocampal synaptosomes, previously
loaded with [3H]glutamate, were stimulated for 30 s with
20 mM K+, they released tritium in a Ca2+-dependent
manner that is mostly [3H]glutamate, as assessed by HPLC
(see Lopes et al., 2002). Two periods of chemical stimula-
tion (S1 and S2), separated by a 6 min interval, produced
a similar evoked tritium release (Fig. 4A), with an S2/S1
ratio of 0.89 ± 0.02 (n = 15). As illustrated in Fig. 4A,
domoate (3M) enhanced by 14 ± 4% (n = 4) the basal
outflow of tritium, in accordance with the ability of kainate
receptors to trigger calcium influx and the spontaneous
release of glutamate from hippocampal nerve terminals
(reviewed in Malva et al., 1998). Consistent with its ef-
fect on glutamatergic transmission, application of 3M
domoate 2 min before the second stimulation period (S2)
caused a decreased K+-evoked release of tritium (Fig. 4A).
As illustrated in Fig. 4B, this inhibitory effect of domoate
on the evoked release of glutamate was attenuated by
88 ± 11% (n = 4) by the ionotropic non-NMDA receptor
antagonist, CNQX (10M), but not by the non-competitive
AMPA receptor antagonist, GYKI 52466 (100M, n = 3).
Also, as illustrated in Fig. 4C, this inhibitory effect of do-
moate (1–10M) on the evoked release of glutamate was
concentration-dependent. As observed when studying gluta-
matergic transmission, AA (10M) decreased the domoate
(1–10M)-induced inhibition of evoked glutamate release
(Fig. 4C).
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Fig. 4. Activation of presynaptic kainate receptors inhibits the evoked
release of glutamate from rat hippocampal synaptosomes and this effect
is attenuated by arachidonic acid. Panel A shown the time course of
[3H]glutamate release, measured as the fractional release expressed in
terms of percentage of total radioactivity present in the synaptosomes at
the beginning of the collection of each sample. The synaptosomes were
challenged with two periods of stimulation with 20 mM K+ for 30 s
(S1 and S2), as indicated by the bars above the abcissa. The symbols
() represent tritium release from a control chamber, to which no drug
was added, and the symbols () represent the tritium release in the
test chamber, to which domoic acid (3M) was added through the
superfusate, as indicated by the upper bar. Note that domoic acid (3M)
enhanced the basal outflow of glutamate and inhibited the evoked release
of glutamate. Panel B shows the ability of the ionotropic non-NMDA
receptor antagonist, CNQX (10M), but not the AMPA receptor antago-
nist, GIKY 52466 (100M), to prevent the effect of domoic acid on the
evoked release of glutamate. The drugs were present in S1 and/or S2 as
indicated under the bars. The results are mean± S.E.M. of three to four
experiments. ∗P < 0.05 vs. the inhibitory effect of domoic acid (first left
column). Panel C shows the concentration-dependent inhibitory effect of
domoic acid on the evoked release of glutamate in the absence () and
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Fig. 5. Inhibition by arachidonic acid of the binding of the selective
kainate receptor agonist, [3H]-(2S,4R)-4-methylglutamate, to synaptoso-
mal membranes of the rat hippocampus. Panel A shows the average sat-
uration curves of [3H]MGA binding in the absence () or presence ()
of AA (10M). The ordinates represent specific binding of [3H]MGA
upon subtraction of the non-specific binding, determined in the presence
of 100M kainate, from total binding. The curves were generated from
the average binding parameters obtained upon fitting by non-linear re-
gression assuming a single binding site. Results are mean ± S.E.M. of
three to nine experiments performed in triplicate. Panel B shows the
concentration-dependent inhibition by AA of the affinity of [3H]MGA
binding, measured as the ratio of the KD values of [3H]MGA in the ab-
sence/presence of AA (KD shift), estimated from saturation curves similar
to these presented in panel A. Each point is the mean± S.E.M. of three
to four experiments.
3.4. Binding to hippocampal synaptosomal membranes
In control conditions, the binding of the kainate re-
ceptor agonist, [3H]-(2S,4R)-4-methylglutamate, to hip-
pocampal synaptosomal membranes displayed a KD of
48 nM (95% confidence interval: 40–55 nM) and a Bmax of
1910±71 fmol/mg protein (n = 9). As illustrated in Fig. 5A,
the presence of AA (10M, n = 3) in the binding assay
in the presence of 10M AA (). Zero percent corresponds to the S2/S1
ratio in control conditions (0.96± 0.04, not modified by 10M AA) and
100% corresponds to the full blockade of the evoked release of tritium
(S2/S1 = 0). The results are mean± S.E.M of three to four experiments.
∗P < 0.05 comparing the effect of each concentration of domoic acid in
the absence and in the presence of 10M AA.
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shifted the saturation isotherm of [3H]MGA binding to the
right, with a 224± 36% increase in KD value (87–125 nM)
and no significant change in Bmax (1872 ± 58 fmol/mg
protein). This inhibition by AA of [3H]MGA binding
was concentration-dependent, increasing from 1 to 10M
(Fig. 5B).
4. Discussion
The main finding of the present work is that AA directly
attenuates the inhibitory effect of presynaptic kainate recep-
tors in glutamatergic nerve terminals of the rat hippocampus.
Thus, AA attenuated the kainate receptor-induced inhibition
of fEPSP slope and facilitation of paired-pulse facilitation
in Schaffer fibre/CA1 pyramid synapses. Furthermore, AA
also attenuated the kainate receptor-induced inhibition of the
evoked release of glutamate from hippocampal nerve termi-
nals. This effect of AA on presynaptic kainate receptors is
likely to be a direct effect of AA, rather than involving intra-
cellular transducing systems, since AA directly attenuated
the binding to kainate receptors in purified membranes from
hippocampal nerve terminals.
Kainate receptors inhibiting glutamatergic transmission
in area CA1 of the hippocampus have previously been de-
scribed (Chittajallu et al., 1996; Kamiya and Ozawa, 1998;
Vignes et al., 1998; Frerking et al., 2001). These kainate
receptors inhibiting glutamatergic transmission are presy-
naptic, as previously proposed (reviewed in Kamiya, 2002),
since both kainate and domoate increased paired-pulse fa-
cilitation (see also Kamiya and Ozawa, 1998) and directly
inhibited the evoked release of glutamate from purified
nerve terminals in a manner sensitive to the ionotropic
non-NMDA receptor antagonist, CNQX, but not to the
selective AMPA receptor antagonist, GYKI 52466 (see
also Chittajallu et al., 1996). This pharmacological profile
indicates the involvement of kainate receptors, which are
enriched in membranes from presynaptic nerve terminals in
the hippocampus (Cunha et al., 1999).
We now observed that AA inhibits presynaptic kainate
receptors, in a manner similar to the previously reported in-
hibition by AA of the cationic current triggered by postsy-
naptic kainate receptors in the hippocampus or by heterol-
ogously expressed kainate receptors (Wilding et al., 1998).
Thus, it appears that AA may interfere with the activation of
kainate receptors by agonists, irrespective of whether kainate
receptors will trigger a cationic current or a metabotropic
action, as is the case of presynaptic kainate receptors in
the CA1 area (Rodrı´guez-Moreno and Lerma, 1998; Cunha
et al., 2000a,b; Frerking et al., 2001). This effect of AA is
likely to be a direct effect not involving lipoxygenase or cy-
clooxygenase metabolites, since the effect of AA was un-
affected by cyclooxigenase or lipoxygenase inhibitors and
was mimicked by the non-hydrolyzable but equi-effective
analogue of AA, EYTA. The possible involvement of free
radicals was also directly excluded by the observation that a
free radical scavenger, N-acetyl-l-cysteine, failed to modify
the effect of AA on kainate receptor-mediated actions. AA
also directly inhibited the binding to kainate receptors in
presynaptic hippocampal membranes, a preparation where
transducing systems are disrupted since there is no intact
cytoplasm, excluding any possible indirect effect of AA on
transducing system controlling kainate receptor function (re-
viewed in Lerma et al., 2001).
In conclusion, the present results further add to previous
observations suggesting that pre- and postsynaptic kainate
receptors display similar pharmacological properties in spite
of the fact that they operate differently (i.e. metabotropic and
inhibitory versus ionotropic and excitatory, respectively).
Further attempts need to be essayed to find ways of phar-
macologically interfering with pre- and postsynaptic kainate
receptors to understand their relative impact on different
physiological and pathological processes (see Lerma et al.,
2001).
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